Skip to main content

Pharma News

pharma courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • New findings on TB could change how we treat inflammatory disorders

    Tuberculosis is a confounding scourge. Its the leading cause of death from infectious disease in the world, and yet its estimated that those deaths represent perhaps 5% of infections with Mycobacterium tuberculosis.
  • Now Graduation mandatory for recruitment as CGHS Pharmacist
    ​The Central Government has released new rules for the recruitment of pharmacists in the Central Government Health Scheme, CGHS. According to the new recruitment rules published in the Government of India Gazette Notification, the minimum educational qualification for recruitment to the post of pharmacist in CGHS has been set to a graduation degree.
  • Gut Bacteria Composition Influences Rotavirus Vaccine Efficacy

    Certain types of gut bacteria can hinder the efficacy of the rotavirus vaccine, according to researchers in the Institute for Biomedical Sciences at Georgia State University.

  • Fasenra approved in China for the treatment of severe eosinophilic asthma
    AstraZeneca Fasenra benralizumab has been approved in China by the country National Medical Products Association NMPA for the maintenance treatment of patients 12 years of age and older with severe eosinophilic asthma.
  • Eugia Pharma receives warning letter from FDA

    Eugia Pharma  receives a warning letter from FDA which summarizes significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals.

    U.S. Food and Drug Administration (FDA) inspected a drug manufacturing facility of Eugia Pharma Specialities Limited (Unit III), at Patancheru (Mandal), Sangareddy, Hyderabad, Telangana, from January 22 to February 2, 2024. It is a wholly owned subsidiary of the Aurobindo Pharma.

  • Indoco Remedies receives ANDA approval from USFDA for Lofexidine

    Indoco Remedies receives final ANDA approval from the USFDA  for Lofexidine Tablets 0.18 mg with Competitive Generic Therapy designation, It is a generic equivalent of Lucemyra Tablets, 0.18 mg of USWM, LLC.

  • Union Health Minister JP Nadda inaugurates First Policy Makers Forum in New Delhi

    Union Minister of Health and Family Welfare & Chemicals and Fertilizers, Shri J.P. Nadda inaugurated the ‘First Policy Makers’ Forum’, here today, which will run until 22nd August 2024. To elevate India's position in the global pharmaceutical sector, the Indian Pharmacopoeia Commission (IPC), in collaboration with the Ministry of Health & Family Welfare and the Ministry of External Affairs, hosted an international delegation of policymakers and drug regulators from 15 countries.

  • Drug delivery method can improve fungal infection treatment
    A unique method developed of drug delivery can prove useful to patients suffering from asthma, cystic fibrosis, or previous lung disease, human immunodeficiency virus HIV, cancer, or those exposed to corticosteroid medications for an extended duration.
  • Granules India Limited Receives ANDA approval for Glycopyrrolate Oral Solution
    Granules India announced that the U.S. Food and Drug Administration has approved its Abbreviated New Drug Application for Glycopyrrolate Oral Solution 1mg/5mL filed by Granules Pharmaceuticals, Inc. , a wholly owned foreign subsidiary of the Company.
  • Nasal spray flu vaccine candidate based on UW–Madison technology shows promise when administered alongside high dose annual shot

    A unique influenza vaccine candidate that’s inhaled and based on technology developed by University of Wisconsin–Madison researchers is safe and could bolster protection against seasonal and pandemic influenza for people vulnerable to severe disease when they receive it in addition to the annual flu shot.

Subscribe to Pharma News